Mustafa Culha (Çulha)[1] is a full professor Chemistry and the founder of Nanobiotechnology and Molecular Engineering Research Group [2] which he established in 2004. He is currently undertaking research for early cancer detection [3] at the Knight Cancer Institute[4] of Oregon Health and Science University.[5] Prof. Culha has significant contributions for the biomedical applications of Surface-enhanced Raman Scattering (SERS), better understanding of surface chemistry versus toxicity relationship of nanomaterials, and synthesis and biomedical applications of boron nitride nanomaterials including boron nitride nanotubes (BNNTs) and hexagonal boron nitrides (hBNs). He continues to explore these and related fields to help the humanity to overcome the biggest challenges in disease detection, diagnosis and treatment.

References

  1. ↑ "Mustafa Culha".
  2. ↑ "Yeditepe University Nanobiotechnology Center". Archived from the original on 2013-11-09. Retrieved 2013-11-09.
  3. ↑ https://www.ohsu.edu/people/mustafa-culha-phd
  4. ↑ "Cancer Hospital and Treatment Center | Knight Cancer Institute | OHSU".
  5. ↑ "Advances in Translational Nanotechnology: Challenges and Opportunities". par.nsf.gov. MDPI Applied Sciences. 2020. Retrieved 22 July 2023.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.